Present status of clofibrate in Canada.
D002170:Canada; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D008079:Lipoproteins, VLDL / Q000378:metabolism
D008079:Lipoproteins, VLDL; D002994:Clofibrate